We are independent & ad-supported. We may earn a commission for purchases made through our links.

Advertiser Disclosure

Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.

How We Make Money

We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently from our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

What are Thiazolidinediones?

Tricia Christensen
By
Updated May 17, 2024
Our promise to you
WiseGEEK is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At WiseGEEK, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

Thiazolidinediones are a group of medications first offered publicly in the late 20th century and principally used as adjunct therapy in the treatment of diabetes type 2. These medicines help the body be less resistant to insulin, which can mean that accompanying insulin therapy is used less and is more useful. Unfortunately, two of the drugs in this group of three have come under fire for grave side effects. One has been pulled from the market and the US Food and Drug Administration (FDA) is still scrutinizing another, as of 2010, as potentially too dangerous to use. For now it carries sharp warnings from the FDA about risk of heart attack.

There are three drugs that are most known as thiazolidinediones. These are Rezulin® (troglitazone), Avandia® (rosiglitazone), and Actos® (pioglitazone). Scientists are developing a few other thiazolidinediones, which are presently not approved medications. As mentioned, one of these medications, troglitazone, is already no longer in use because it had a tendency to cause a form of hepatitis or liver disease that is drug induced.

The other medication that has created significant controversy is Avandia®. There is a measurable increase in heart attack risk when this drug is taken, and patients with heart disease should not risk it. Where it is of most concern is when people are unaware of evidence of heart disease and take the drug anyway. The principal issue seems to be that all thiazolidinediones can cause some water retention, and this can overload the heart and make heart attack more likely. Avandia® remains on the market with a much more limited prescribing range.

To avoid this increased risk, people may turn to Actos® instead, which isn’t associated with higher heart attack rate, though it still may not be prescribed to those with heart disease. It should also be noted that with the two thiazolidinediones available, only about one in 20 people taking the drug get edema or fluid retention, and the risk of heart attack as a result of edema is far lower. Should edema develop, physicians usually immediately discontinue the medication. The best thing to do if this matter is of concern is to discuss it with a physician.

A few other side effects of thiazolidinediones exist. Sometimes people have elevated cholesterol, though some people may have lowered cholesterol when taking these medications. Other people experience cold or flu symptoms, cough, headaches, cramps in the muscles or weight gain. Doctors need to be consulted if people have extreme stomach cramping, vomiting, jaundice, trouble breathing or any potential symptoms of heart attack or failure.

Unrelated to diabetes treatment is the use of thiazolidinediones to correct fertility issues or gynecological problems. Though not an approved use, sometimes these medicines are employed to stimulate ovulation. They may also address problems caused by polycystic ovarian disease. Yet given the warnings associated with some of these medicines, particularly Avandia®, thiazolidinediones may not get used in this manner very often.

WiseGEEK is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Tricia Christensen
By Tricia Christensen , Writer
With a Literature degree from Sonoma State University and years of experience as a WiseGEEK contributor, Tricia Christensen is based in Northern California and brings a wealth of knowledge and passion to her writing. Her wide-ranging interests include reading, writing, medicine, art, film, history, politics, ethics, and religion, all of which she incorporates into her informative articles. Tricia is currently working on her first novel.

Discussion Comments

Tricia Christensen

Tricia Christensen

Writer

With a Literature degree from Sonoma State University and years of experience as a WiseGEEK contributor, Tricia...
Learn more
WiseGEEK, in your inbox

Our latest articles, guides, and more, delivered daily.

WiseGEEK, in your inbox

Our latest articles, guides, and more, delivered daily.